Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Sos recruitment system for the analysis of the interaction between sulfatase-modifying factor 2 subtypes and interleukin-13.

Zhang WY, Liang HY, Yang C, Xue L, Jiang XF.

Genet Mol Res. 2013 Nov 18;12(4):5664-72. doi: 10.4238/2013.November.18.15.

2.

SUMF2 interacts with interleukin-13 and inhibits interleukin-13 secretion in bronchial smooth muscle cells.

Liang H, Li Z, Xue L, Jiang X, Liu F.

J Cell Biochem. 2009 Dec 1;108(5):1076-83. doi: 10.1002/jcb.22336.

PMID:
19739097
3.

Downregulation of SUMF2 gene in ovalbumin-induced rat model of allergic inflammation.

Fang C, Li X, Liang H, Xue L, Liu L, Yang C, Gao G, Jiang X.

Int J Clin Exp Pathol. 2015 Oct 1;8(10):12053-63. eCollection 2015.

4.

Sulphatase activities are regulated by the interaction of sulphatase-modifying factor 1 with SUMF2.

Zito E, Fraldi A, Pepe S, Annunziata I, Kobinger G, Di Natale P, Ballabio A, Cosma MP.

EMBO Rep. 2005 Jul;6(7):655-60. Erratum in: EMBO Rep. 2016 Dec;17 (12 ):1901.

5.
6.
7.

[Construction of a bait plasmid containing HBV PreS1 gene in a yeast two-hybrid system and evaluation of its toxicity and self-activation].

Zhang X, Lin SM, Wu LX, Chen TY, Ye F, Zhao YR, Zhang SL.

Nan Fang Yi Ke Da Xue Xue Bao. 2009 Oct;29(10):1955-9. Chinese.

8.

HpSumf1 is involved in the activation of sulfatases responsible for regulation of skeletogenesis during sea urchin development.

Sakuma T, Ohnishi K, Fujita K, Ochiai H, Sakamoto N, Yamamoto T.

Dev Genes Evol. 2011 Aug;221(3):157-66. doi: 10.1007/s00427-011-0368-2. Epub 2011 Jun 27.

PMID:
21706447
9.

Posttranslational modification of serine to formylglycine in bacterial sulfatases. Recognition of the modification motif by the iron-sulfur protein AtsB.

Marquordt C, Fang Q, Will E, Peng J, von Figura K, Dierks T.

J Biol Chem. 2003 Jan 24;278(4):2212-8. Epub 2002 Nov 4.

10.

Interleukin-13 regulates secretion of the tumor growth factor-{beta} superfamily cytokine activin A in allergic airway inflammation.

Hardy CL, Lemasurier JS, Olsson F, Dang T, Yao J, Yang M, Plebanski M, Phillips DJ, Mollard R, Rolland JM, O'Hehir RE.

Am J Respir Cell Mol Biol. 2010 Jun;42(6):667-75. doi: 10.1165/rcmb.2008-0429OC. Epub 2009 Jul 27.

PMID:
19635933
11.

Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics.

Candolfi M, Xiong W, Yagiz K, Liu C, Muhammad AK, Puntel M, Foulad D, Zadmehr A, Ahlzadeh GE, Kroeger KM, Tesarfreund M, Lee S, Debinski W, Sareen D, Svendsen CN, Rodriguez R, Lowenstein PR, Castro MG.

Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):20021-6. doi: 10.1073/pnas.1008261107. Epub 2010 Oct 28.

12.

Molecular regulation of interleukin-13 and monocyte chemoattractant protein-1 expression in human mast cells by interleukin-1beta.

Lee SA, Fitzgerald SM, Huang SK, Li C, Chi DS, Milhorn DM, Krishnaswamy G.

Am J Respir Cell Mol Biol. 2004 Sep;31(3):283-91. Epub 2004 Jun 10.

PMID:
15191916
13.

A common variant associated with asthma, interleukin 13 R130Q, promotes the production of IgE.

Chu Y, Hua L, Liu Q, Bao Y.

Int J Immunogenet. 2012 Aug;39(4):308-13. doi: 10.1111/j.1744-313X.2012.01091.x. Epub 2012 Feb 10.

PMID:
22325047
14.

Sulfatase activities are regulated by the interaction of the sulfatase-modifying factor 1 with SUMF2.

Zito E, Fraldi A, Pepe S, Annunziata I, Kobinger G, Di Natale P, Ballabio A, Cosma MP.

EMBO Rep. 2016 Dec;17(12):1901. No abstract available.

15.

MIP-T3 associates with IL-13Ralpha1 and suppresses STAT6 activation in response to IL-13 stimulation.

Niu Y, Murata T, Watanabe K, Kawakami K, Yoshimura A, Inoue J, Puri RK, Kobayashi N.

FEBS Lett. 2003 Aug 28;550(1-3):139-43.

16.

Leukotriene D4 and interleukin-13 cooperate to increase the release of eotaxin-3 by airway epithelial cells.

Provost V, Langlois A, Chouinard F, Rola-Pleszczynski M, Chakir J, Flamand N, Laviolette M.

PLoS One. 2012;7(8):e43544. doi: 10.1371/journal.pone.0043544. Epub 2012 Aug 31.

17.

STAT6 links IL-4/IL-13 stimulation with pendrin expression in asthma and chronic obstructive pulmonary disease.

Nofziger C, Vezzoli V, Dossena S, Schönherr T, Studnicka J, Nofziger J, Vanoni S, Stephan S, Silva ME, Meyer G, Paulmichl M.

Clin Pharmacol Ther. 2011 Sep;90(3):399-405. doi: 10.1038/clpt.2011.128. Epub 2011 Aug 3.

PMID:
21814192
18.

Cloning of a mucin-desulfating sulfatase gene from Prevotella strain RS2 and its expression using a Bacteroides recombinant system.

Wright DP, Knight CG, Parkar SG, Christie DL, Roberton AM.

J Bacteriol. 2000 Jun;182(11):3002-7.

19.

Multiple sulfatase deficiency is due to hypomorphic mutations of the SUMF1 gene.

Annunziata I, Bouchè V, Lombardi A, Settembre C, Ballabio A.

Hum Mutat. 2007 Sep;28(9):928.

PMID:
17657823
20.

Mechanism of action of interleukin-13 antagonist (IL-13E13K) in cells expressing various types of IL-4R.

Kioi M, Kawakami K, Puri RK.

Cell Immunol. 2004 May;229(1):41-51.

PMID:
15331327

Supplemental Content

Support Center